Literature DB >> 33489036

Decreased expression of endothelial cell specific molecule-1 in lung tissue in emphysematous mice and stable COPD patients.

Yan Zhang1,2,3, Ping Chen1,2,3, Shan Cai1,2,3, Jinhua Li1,2,3, Yan Chen1,2,3.   

Abstract

OBJECTIVES: Apoptosis of pulmonary alveolar septal cells is a pathogenesis characteristic of chronic obstructive pulmonary disease (COPD). Endothelial cell specific molecule-1 (ESM-1) plays an important role in apoptosis of cells. Here, we aimed to determine whether ESM-1 can involve in cell apoptosis in emphysematous mice and stable COPD patients. The sample size of patients was small, so two separate models were studied.
MATERIALS AND METHODS: At day 0, 11, and 22, murine were injected IP with 0.3 ml of PBS/Cigarette smoke extract, and euthanized at day 28. Lung tissues from 20 stable COPD patients and 12 Controls were evaluated. Serum was obtained from 25 stable COPD patients and 12 healthy Controls. Pulmonary function, pathology, pulmonary apoptosis index (AI), expression of vascular endothelial growth factor (VEGF), hepatocyte growth factor (HGF) and ESM-1 in lung tissue, and concentration of ESM-1 in serum were tested.
RESULTS: Protein expression of ESM-1, VEGF and HGF were decreased significantly in emphysematous mice (P<0.05), while AI was increased (P<0.05). Correlation analysis indicated that association between AI and ESM-1 was negative (P<0.01), VEGF and ESM-1 was positive (P<0.01), and HGF and ESM-1 was positive (P<0.01). In stable COPD patients, we proved that ESM-1, VEGF and HGF were decreased significantly, while AI was increased (P<0.05). Correlation between AI and ESM-1 was negative (P<0.01), VEGF and ESM-1 was positive (P<0.01), and HGF and ESM-1 was positive (P<0.01).
CONCLUSION: ESM-1 expression decreased and AI increased in emphysematous mice and stable COPD patients. Findings suggested that ESM-1 may be involved in anti-apoptotic therapy of COPD.

Entities:  

Keywords:  Alveolar; Apoptosis; Chronic obstructive - pulmonary disease; Endothelial cell specific - molecule-1; Hepatocyte growth factor; Vascular endothelial growth- factor

Year:  2020        PMID: 33489036      PMCID: PMC7811818          DOI: 10.22038/ijbms.2020.44243.10384

Source DB:  PubMed          Journal:  Iran J Basic Med Sci        ISSN: 2008-3866            Impact factor:   2.699


  27 in total

1.  Low endocan levels are predictive of Acute Respiratory Distress Syndrome in severe sepsis and septic shock.

Authors:  Alexandre Gaudet; Erika Parmentier; Sylvain Dubucquoi; Julien Poissy; Thibault Duburcq; Philippe Lassalle; Nathalie De Freitas Caires; Daniel Mathieu
Journal:  J Crit Care       Date:  2018-06-20       Impact factor: 3.425

2.  ESM-1: A Novel Tumor Biomaker and its Research Advances.

Authors:  Chen Li; Hui Geng; Linhua Ji; Xiaojing Ma; Qichao Yin; Hua Xiong
Journal:  Anticancer Agents Med Chem       Date:  2019       Impact factor: 2.505

3.  Downregulation of ENDOCAN in myeloid leukemia cells inhibits proliferation and promotes apoptosis by suppressing nuclear factor‑κB activity.

Authors:  Lingling Sun; Chengyu Sun; Jiaying Sun; Wei Yang
Journal:  Mol Med Rep       Date:  2019-02-19       Impact factor: 2.952

4.  Cloning and characterization of the human lung endothelial-cell-specific molecule-1 promoter.

Authors:  Jo C Tsai; Jie Zhang; Takashi Minami; Carole Voland; Shuping Zhao; Xianjin Yi; Philippe Lassalle; Peter Oettgen; William C Aird
Journal:  J Vasc Res       Date:  2002 Mar-Apr       Impact factor: 1.934

5.  Recombinant Human Keratinocyte Growth Factor Induces Akt Mediated Cell Survival Progression in Emphysematous Mice.

Authors:  Jai Prakash Muyal; Dhananjay Kumar; Sudhir Kotnala; Vandana Muyal; Amit Kumar Tyagi
Journal:  Arch Bronconeumol       Date:  2014-07-10       Impact factor: 4.872

6.  Neutrophil Elastase Differentially Regulates Interleukin 8 (IL-8) and Vascular Endothelial Growth Factor (VEGF) Production by Cigarette Smoke Extract.

Authors:  Kyoung-Hee Lee; Chang-Hoon Lee; Jiyeong Jeong; An-Hee Jang; Chul-Gyu Yoo
Journal:  J Biol Chem       Date:  2015-10-09       Impact factor: 5.157

7.  Human mesenchymal stromal cells exert HGF dependent cytoprotective effects in a human relevant pre-clinical model of COPD.

Authors:  Helen Kennelly; Bernard P Mahon; Karen English
Journal:  Sci Rep       Date:  2016-12-06       Impact factor: 4.379

8.  Association of NLRP1 Coding Polymorphism with Lung Function and Serum IL-1β Concentration in Patients Diagnosed with Chronic Obstructive Pulmonary Disease (COPD).

Authors:  Petar Ozretić; Miguel Inacio da Silva Filho; Calogerina Catalano; Irena Sokolović; Andrea Vukić-Dugac; Maja Šutić; Matea Kurtović; Gordana Bubanović; Sanja Popović-Grle; Sanda Skrinjarić-Cincar; Oliver Vugrek; Irena Jukić; Lada Rumora; Martina Bosnar; Miroslav Samaržija; Robert Bals; Marko Jakopović; Asta Försti; Jelena Knežević
Journal:  Genes (Basel)       Date:  2019-10-09       Impact factor: 4.096

9.  Human adipose-derived mesenchymal stem cell spheroids improve recovery in a mouse model of elastase-induced emphysema.

Authors:  Ryeon Jin Cho; You-Sun Kim; Ji-Young Kim; Yeon-Mok Oh
Journal:  BMB Rep       Date:  2017-02       Impact factor: 4.778

10.  Endocan silencing induces programmed cell death in hepatocarcinoma.

Authors:  Jinghui Yang; Shihou Sheng; Qiwei Yang; Li Li; Shaoyou Qin; Shan Yu; Xuewen Zhang
Journal:  Oncol Lett       Date:  2017-08-31       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.